Skip to main content
Premium Trial:

Request an Annual Quote

NIH Grants for Pharmacogenomics Research FY 06 April 9 -- May 14*

Premium
NIH Grants for Pharmacogenomics Research FY'06
April 9 — May 14*
City, State, or Country Name
Organization Name
Principal Investigator
Award
Title
Alabama
Birmingham
University of Alabama at Birmingham Zhang, Kui
$218,250
Haplotype Analysis in Linkage Disequilibrium Mapping
California
San Diego
San Diego State University Mccarthy, Jeanette J
$224,250
Pharmacogenetics of lipid response to estrogen therapy
Palo Alto Roche Palo Alto Peltz, Gary A
$290,533
Pharmacogenetic Analysis in Mice
Florida
Tallahassee
Florida State University Beerli, Peter
$143,262
Improving population genetics parameter estimation based on SNPs
France
Lyon
World Health Organization International Agency Resolution on Cancer Hashibe, Mia
$110,345
Pooled Analyses of SNPs and Risk of Head & Neck Cancer
Maryland
Baltimore
Johns Hopkins Univesity Small, Donald M
$166,718
FLT3 Tyrosine Kinase Inhibitors As Therapy for Leukemia
Massachusetts
Cambridge
Massachusetts Institute of Technology Sklar, Pamela B
$723,096
Haplotype Mapping of Chromosome 5 Schizophrenia Locus
Mississippi
University
University of Mississippi Willett, Kristine L
$231,382
Roles of CYP1 & 19 in Fundulus Steroids & PAH Metabolism
Missouri
Kansas City
Children's Mercy Hospital Kansas City Neville, Kathleen A
$152,523
Pharmacogenetics of Pediatric Sickle Cell Disease
New York
Rochester
Enslein Research Enslein, Kurt Nmi
$155,415
QSAR Models: Human CYP450 Drug Metabolism and Kinetics
New York Mount Sinai School of Medicine Cederbaum, Arthur I
$502,942
Effects of ethanol and CYP2E1 on liver function
Pennsylvania
Pittsburgh
University of Pittsburgh Lotrich, Francis E
$173,556
Pharmacogenomics of Interferon-Induced Depression
Philadelphia University of Pennsylvania Meggers, Eric
$218,148
Metal Complexes as Protein Kinase Inhibitors
Puerto Rico
Ponce
Ponce School of Medicine Flores, Idhaliz
$321,449
SNP Analysis of Endometriosis Candidate Genes
Tennessee
Memphis
St. Jude's Children's Research Hospital Evans, William E
$579,787
Pharmacogenomics of Childhood Leukemia (ALL)
Texas
Houston
University of Texas MD Anderson Cancer Center Hung, Mienchie
$302,276
HER2 in Breast Tumor Progression and Metastasis
University of Texas MD Anderson Cancer Center Krasnykh, Victor
$309,580
Her2-targeted vectors for gene therapy of cancer
Washington
Seattle
University of Washington Thummel, Kenneth E
$439,862
Pharmacogenomics of ADRs: Calcineurin Inhibitor Toxicity
Fred Hutchinson Cancer Research Center Zhao, Lueping
$372,852
Methods for Correlating SNP Haplotypes with Cancer
*SOURCE: US National Institutes of Health

Filed under

The Scan

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.

Tibetan Study Finds Adaptive Variant Influencing Skin Pigmentation

With a combination of phenotyping and genetic data, researchers document at PNAS a Tibetan-enriched enhancer variant influencing melanin synthesis and ultraviolet light response.

Domestication Linked to Nervous System Genes in Inbred Mouse Strains

Researchers highlighted more than 300 positively selected genes in domesticated mice, including genes linked to nervous system function or behavior in Genome Biology.

ALS Genetic Testing May Be Informative Across Age Ranges, Study Finds

Researchers in the journal Brain identified clinically actionable variants in a significant subset of older ALS patients, prompting them to point to the potential benefits of broader test use.